Matches in Nanopublications for { ?s ?p "[In the present study, we genetically engineered human blood-derived endothelial colony-forming cells (ECFCs) to express erythropoietin (EPO) under the control of a tetracycline-regulated system, and generated subcutaneous vascular networks capable of systemic EPO release in immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[In the present study, we genetically engineered human blood-derived endothelial colony-forming cells (ECFCs) to express erythropoietin (EPO) under the control of a tetracycline-regulated system, and generated subcutaneous vascular networks capable of systemic EPO release in immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_assertion description "[In the present study, we genetically engineered human blood-derived endothelial colony-forming cells (ECFCs) to express erythropoietin (EPO) under the control of a tetracycline-regulated system, and generated subcutaneous vascular networks capable of systemic EPO release in immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP444200.RA6FG0A2mdt74m-4FLT9uTr_wSjaHeuxmzA9I2M21U7ts130_provenance.
- NP377885.RAgEIbRsawtLbaNiFU6RVPgcZtYqaCmrfB-hcez9S68RI130_assertion description "[In the present study, we genetically engineered human blood-derived endothelial colony-forming cells (ECFCs) to express erythropoietin (EPO) under the control of a tetracycline-regulated system, and generated subcutaneous vascular networks capable of systemic EPO release in immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP377885.RAgEIbRsawtLbaNiFU6RVPgcZtYqaCmrfB-hcez9S68RI130_provenance.
- NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_assertion description "[In the present study, we genetically engineered human blood-derived endothelial colony-forming cells (ECFCs) to express erythropoietin (EPO) under the control of a tetracycline-regulated system, and generated subcutaneous vascular networks capable of systemic EPO release in immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_provenance.